John Clarke
InvestorManaging Partner at Cardinal Partners · Board director at Vividion Therapeutics · Non-Management Director at aTYR PHARMA · Board director at Ivenix
Alvin, Texas, United States
Find your path to John
250 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
About
John Clarke is a Managing Partner at Cardinal Partners, which he co-founded in 1997, and brings over three decades of early-stage venture capital experience. He leads the firm's life sciences investment practice and has led or directed investments in multiple publicly traded pharmaceutical and healthcare companies. Prior to Cardinal, he spent 15 years at DSV Partners, where he managed the firm's healthcare and life sciences portfolio and served as interim CEO of several successful companies.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- j•••@cardinalpartners.comreveal100% confident
Invests in
BiotechHealthtechMedical Devices
Board director at Vividion Therapeutics
Intro paths
In turn, John can intro founders to Vividion Therapeutics's investors below.
Vividion Therapeutics's investors · 6
Co-founders at Vividion Therapeutics
Non-Management Director at aTYR PHARMA
Intro paths
In turn, John can intro founders to aTYR PHARMA's investors below.
aTYR PHARMA's investors · 8
Co-founders at aTYR PHARMA
Board director at Ivenix
Intro paths
In turn, John can intro founders to Ivenix's investors below.
Deals · 4
Cardinal AnalytxBoard seat
via Cardinal Partners · filed Mar 2018 · $2M raise
aTYR PHARMABoard seat
via Cardinal Partners · filed Apr 2015 · $76.3M raise
AlkermesLed round
VerastemLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Alnylam PharmaceuticalsArris PharmaceuticalsCubist PharmaceuticalsDNXMomenta PharmaceuticalsSirtris Pharmaceuticals
Board seats
Abide TherapeuticsIvenixTechRx CorporationVisicuVividion Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Cardinal Partners
Network1
Investors connected to John in public investor directories — a warm-intro map.
Frequently asked questions
- Who is John Clarke?
- John Clarke is a Managing Partner at Cardinal Partners, which he co-founded in 1997, and brings over three decades of early-stage venture capital experience. He leads the firm's life sciences investment practice and has led or directed investments in multiple publicly traded pharmaceutical and healthcare companies. Prior to Cardinal, he spent 15 years at DSV Partners, where he managed the firm's healthcare and life sciences portfolio and served as interim CEO of several successful companies.
- Where does John Clarke work?
- John Clarke is Managing Partner at Cardinal Partners and Board director at Vividion Therapeutics and Non-Management Director at aTYR PHARMA and Board director at Ivenix.
- What does John Clarke invest in?
- John Clarke invests in Biotech, Healthtech, Medical Devices.
- What boards does John Clarke sit on?
- John Clarke holds tracked board seats at Abide Therapeutics, aTyr Pharma, aTYR PHARMA, Cardinal Analytx, Ivenix, TechRx Corporation, Visicu, Vividion Therapeutics.
- What companies has John Clarke invested in?
- Investments tracked here include Alkermes, Alnylam Pharmaceuticals, Arris Pharmaceuticals, Cubist Pharmaceuticals, DNX, Momenta Pharmaceuticals, Sirtris Pharmaceuticals, Verastem.
- Does John Clarke lead rounds?
- Yes — John Clarke has led 8 tracked investments.